Dexamethasone
Dexamethasone.JPG

Dexamethasone

CLINICAL USE

Corticosteroid:Cerebral oedema Suppression of inflammatory and allergic disordersRheumatic disease Congenital adrenal hyperplasia Anti-emetic (unlicensed indication)

DOSE IN NORMAL RENAL FUNCTION

Cerebral oedema: 10 mg IV followed by 4 mg IM every 6 hoursRheumatic disease: intra-articular, intrasynovial: 0.4–4 mg —(as dexamethasone phosphate)soft tissue infiltration: 2–6 mg —Oral: 0.5–10 mg daily, IV/IM: 0.5–24 mg

PHARMACOKINETICS

  • Molecular weight                           :392.5 (472.4 as phosphate)
  • %Protein binding                           :77
  • %Excreted unchanged in urine     : 65
  • Volume of distribution (L/kg)       :0.8–1
  • half-life – normal/ESRD (hrs)      :3.5–4.5/–

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Removal unlikely. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsAntibacterials: metabolism accelerated by rifampicin; metabolism possibly inhibited by erythromycinAnticoagulants: efficacy of coumarins may be alteredAnti-epileptics: metabolism accelerated by carbamazepine, barbiturates, phenytoin and primidoneAntifungals: increased risk of hypokalaemia with amphotericin – avoid concomitant use; metabolism possibly inhibited by itraconazole and ketoconazole; caspofungin concentration possibly reduced (may need to increase dose). Antivirals: concentration of indinavir, lopinavir and saquinavir possibly reduced; concentration possibly increased by ritonavirCiclosporin: rare reports of convulsions in patients on ciclosporin and high-dose corticosteroidsCytotoxics: increased risk of haematological toxicity with methotrexateDiuretics: enhanced hypokalaemic effects of acetazolamide, loop diuretics and thiazide diureticsVaccines: high dose corticosteroids can impair immune response to vaccines; avoid concomitant use with live vaccines

    ADMINISTRATION

    Reconstition

    Route

    Oral, IV, IM, intra-articular, intrasynovial

    Rate of Administration

    IV slowly over not less than 5 minutes. If underlying cardiac pathology, infusion over 20–30 minutes advised

    Comments

    OTHER INFORMATION

    Dexamethasone sodium phosphate 1.3 mg = dexamethasone 1 mg750 mcg of dexamethasone is equivalent to 5 mg prednisolone Injection solution can be administered orally or via naso-gastric tubeTablets will disperse in water



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs